Stocks Overview

LAST PRICE
27.1700
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
27.1700/ 2
Ask / Lots
28.3000/ 1
Open / Previous Close
0.0000 / 27.1700
Day Range
---
52 Week Range
Low 25.9200
High 34.6500
Volume
---
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Monday's close: 27.48
Time	Volume	RPRX
09:32 ET	30705	27.37
09:34 ET	3562	27.4
09:36 ET	900	27.3049
09:38 ET	2252	27.26
09:39 ET	2556	27.33
09:41 ET	3077	27.36
09:43 ET	882	27.39
09:45 ET	13272	27.46
09:48 ET	35859	27.5
09:50 ET	3885	27.51
09:52 ET	6899	27.515
09:54 ET	92630	27.48
09:56 ET	12719	27.51
09:57 ET	2925	27.42
09:59 ET	4717	27.51
10:01 ET	1445	27.5
10:03 ET	30531	27.5
10:06 ET	4154	27.59
10:08 ET	12903	27.59
10:10 ET	2481	27.575
10:12 ET	3804	27.5666
10:14 ET	6045	27.58
10:15 ET	35888	27.67
10:17 ET	7178	27.69
10:19 ET	3733	27.645
10:21 ET	12372	27.585
10:24 ET	2359	27.625
10:26 ET	1924	27.615
10:28 ET	1900	27.615
10:30 ET	10072	27.65
10:32 ET	8744	27.615
10:33 ET	13178	27.61
10:35 ET	38177	27.48
10:37 ET	7156	27.49
10:39 ET	5500	27.485
10:42 ET	2531	27.535
10:44 ET	2465	27.51
10:46 ET	2001	27.51
10:48 ET	5898	27.5
10:50 ET	5155	27.52
10:51 ET	4521	27.515
10:53 ET	500	27.495
10:55 ET	4047	27.4915
10:57 ET	9596	27.47
11:00 ET	7476	27.445
11:02 ET	12188	27.46
11:04 ET	11987	27.455
11:06 ET	3927	27.455
11:08 ET	3802	27.445
11:09 ET	4356	27.445
11:11 ET	3600	27.445
11:13 ET	8153	27.425
11:15 ET	7773	27.43
11:18 ET	26073	27.47
11:20 ET	1558	27.48
11:22 ET	1774	27.49
11:24 ET	1300	27.45
11:26 ET	1000	27.435
11:27 ET	3319	27.43
11:29 ET	3629	27.36
11:31 ET	6543	27.31
11:33 ET	2353	27.315
11:36 ET	2139	27.32
11:38 ET	6850	27.31
11:40 ET	1238	27.31
11:42 ET	7406	27.33
11:44 ET	919	27.335
11:45 ET	9740	27.3543
11:47 ET	648	27.355
11:49 ET	6743	27.34
11:51 ET	8162	27.355
11:54 ET	599	27.36
11:56 ET	1765	27.34
11:58 ET	5500	27.325
12:00 ET	10915	27.34
12:02 ET	2041	27.34
12:03 ET	1800	27.3349
12:05 ET	1700	27.32
12:07 ET	3067	27.34
12:09 ET	445	27.335
12:12 ET	6422	27.355
12:14 ET	4000	27.335
12:16 ET	3250	27.32
12:18 ET	2200	27.33
12:20 ET	4464	27.33
12:21 ET	5907	27.335
12:23 ET	1700	27.325
12:25 ET	4390	27.325
12:27 ET	9325	27.355
12:30 ET	5811	27.355
12:32 ET	17237	27.37
12:34 ET	8293	27.38
12:36 ET	948	27.37
12:38 ET	2433	27.3752
12:39 ET	5036	27.38
12:41 ET	1485	27.365
12:43 ET	100	27.365
12:45 ET	6759	27.39
12:48 ET	12191	27.405
12:50 ET	2545	27.385
12:52 ET	1800	27.415
12:54 ET	1715	27.4065
12:56 ET	896	27.415
12:57 ET	4498	27.4
12:59 ET	200	27.4
01:01 ET	2498	27.38
01:03 ET	800	27.38
01:06 ET	2675	27.35
01:08 ET	1000	27.32
01:10 ET	4519	27.33
01:12 ET	300	27.31
01:14 ET	3047	27.33
01:15 ET	2771	27.32
01:17 ET	1082	27.32
01:19 ET	7781	27.37
01:21 ET	2490	27.34
01:24 ET	339	27.3343
01:26 ET	4771	27.3401
01:28 ET	3208	27.355
01:30 ET	2378	27.365
01:32 ET	8930	27.375
01:33 ET	5059	27.38
01:35 ET	3132	27.37
01:37 ET	1300	27.375
01:39 ET	9692	27.385
01:42 ET	1100	27.39
01:44 ET	16641	27.365
01:46 ET	1390	27.355
01:48 ET	1604	27.351
01:50 ET	2145	27.32
01:51 ET	5254	27.32
01:53 ET	3618	27.335
01:55 ET	700	27.345
01:57 ET	1600	27.34
02:00 ET	3100	27.325
02:04 ET	4045	27.31
02:06 ET	200	27.315
02:08 ET	3562	27.305
02:09 ET	3763	27.3
02:11 ET	2651	27.3
02:13 ET	970	27.295
02:15 ET	64544	27.305
02:18 ET	4080	27.325
02:20 ET	3115	27.29
02:22 ET	3517	27.295
02:24 ET	3149	27.305
02:26 ET	2943	27.305
02:27 ET	1265	27.315
02:29 ET	3459	27.325
02:31 ET	11208	27.32
02:33 ET	3016	27.305
02:36 ET	100	27.3
02:38 ET	1300	27.275
02:40 ET	3538	27.28
02:42 ET	1729	27.265
02:44 ET	2517	27.255
02:45 ET	7046	27.255
02:47 ET	400	27.255
02:49 ET	1640	27.255
02:51 ET	4816	27.23
02:54 ET	9656	27.23
02:56 ET	1451	27.235
02:58 ET	1195	27.235
03:00 ET	9752	27.205
03:02 ET	3769	27.19
03:03 ET	1608	27.195
03:05 ET	2995	27.1731
03:07 ET	15061	27.16
03:09 ET	2359	27.155
03:12 ET	4733	27.145
03:14 ET	11882	27.155
03:16 ET	5667	27.165
03:18 ET	5537	27.17
03:20 ET	5881	27.14
03:21 ET	3781	27.125
03:23 ET	16622	27.12
03:25 ET	4749	27.15
03:27 ET	7539	27.145
03:30 ET	4234	27.14
03:32 ET	8739	27.15
03:34 ET	3495	27.14
03:36 ET	7895	27.135
03:38 ET	1818	27.125
03:39 ET	5099	27.115
03:41 ET	7822	27.11
03:43 ET	11564	27.135
03:45 ET	17231	27.1
03:48 ET	2990	27.105
03:50 ET	12578	27.11
03:52 ET	26228	27.105
03:54 ET	11760	27.09
03:56 ET	56677	27.185
03:57 ET	40933	27.195
03:59 ET	299665	27.17

Data delayed at least 15 minutes.

May 17, 2024
- DJ S&P 500 Futures Steady In Premarket Trading; RBC Bearings, GameStop Lag, from 7:31AM ET on Friday May 17, 2024 by Dow Jones
  7:31AM ET on Friday May 17, 2024 by Dow Jones
May 13, 2024
- Royalty Pharma to Present at Upcoming Investor Conferences, from 8:15AM ET on Monday May 13, 2024 by Dow Jones
  8:15AM ET on Monday May 13, 2024 by Dow Jones
May 9, 2024
- Royalty Pharma Reports First Quarter 2024 Results, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones
  7:00AM ET on Thursday May 09, 2024 by Dow Jones
- *DJ Royalty Pharma 1Q Net $5M >RPRX, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones
  7:00AM ET on Thursday May 09, 2024 by Dow Jones
- Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab, from 6:45AM ET on Thursday May 09, 2024 by Dow Jones
  6:45AM ET on Thursday May 09, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRPRX Royalty Pharma PLC	16.2B	15.2x	+1.83%
United StatesAMRX Amneal Pharmaceuticals Inc	2.1B	-11.9x	---
United StatesCTLT Catalent Inc	9.9B	-8.5x	---
United StatesJAZZ Jazz Pharmaceuticals PLC	6.7B	22.1x	-3.53%
United StatesMCKPF Mallinckrodt PLC	1.6M	0.0x	---
United StatesPBH Prestige Consumer Healthcare Inc	3.2B	15.6x	---
As of 2024-05-22

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.

Contact Information

Headquarters: 110 East 59th StreetNEW YORK, NY, United States 10022
Phone: 212-883-0200
Fax: ---

Executives

Chairman of the Board, Chief Executive Officer: Pablo Legorreta
Vice Chairman, Executive Vice President: Christopher Hite
Chief Financial Officer, Executive Vice President: Terrance Coyne
Executive Vice President - Investments and Chief Legal Officer: George Lloyd
Executive Vice President - Research and Investments: Marshall Urist

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$16.2B
Revenue (TTM)	$2.2B
Shares Outstanding	597.4M
Dividend Yield	3.09%
Annual Dividend Rate	0.8400 USD
Ex-Dividend Date	05-16-24
Pay Date	06-14-24
Beta	0.46
EPS	$1.78
Book Value	$14.61
P/E Ratio	15.2x
Price/Sales (TTM)	7.3
Price/Cash Flow (TTM)	13.6x
Operating Margin	41.96%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Royalty Pharma PLC
NASDAQ:RPRXUnited States

Search Criteria

Charts

Recent News

May 17, 2024

DJ S&P 500 Futures Steady In Premarket Trading; RBC Bearings, GameStop Lag, from 7:31AM ET on Friday May 17, 2024 by Dow Jones

May 13, 2024

Royalty Pharma to Present at Upcoming Investor Conferences, from 8:15AM ET on Monday May 13, 2024 by Dow Jones

May 9, 2024

Royalty Pharma Reports First Quarter 2024 Results, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones

*DJ Royalty Pharma 1Q Net $5M >RPRX, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones

Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab, from 6:45AM ET on Thursday May 09, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar